Skip to main content

AusPAR: Comirnaty Omicron XBB.1.5

Australian Public Assessment Report
Device/Product Name
Comirnaty Omicron XBB.1.5
Active ingredients
Raxtozinameran
AusPAR Date
Published
Submission Number
PM-2023-03730-1-2
Submission Type
Major variation (update in strain) and new formulation
Decision
Approved

Help us improve the Therapeutic Goods Administration site